Cytomx Therapeutics, Inc. · NASDAQ:CTMX

BVF PARTNERS L P/IL's stake in Cytomx Therapeutics, Inc. fell to 3.50% (Schedule 13G/A)

Event Jul 3, 2025 · Filed Jul 9, 2025

BVF PARTNERS L P/IL's stake in Cytomx Therapeutics, Inc. fell to 3.50%, 5,769,231 shares, as a passive investor on Jul 3, 2025. Filed Jul 9, 2025 (Schedule 13G/A).

Stake
3.50%
Shares
5,769,231
Intent
Passive
What changed
Fell below 5%
Filed together
10 holders

The filing in full

HolderStakeShares
BIOTECHNOLOGY VALUE FUND L P1.90%3,074,013
BVF I GP LLC1.90%3,074,013
BIOTECHNOLOGY VALUE FUND II LP1.50%2,351,446
BVF II GP LLC1.50%2,351,446
Biotechnology Value Trading Fund OS LP0.20%270,616
BVF Partners OS Ltd.0.20%270,616
BVF GP HOLDINGS LLC3.30%5,425,459
BVF PARTNERS L P/IL3.50%5,769,231
BVF INC/IL3.50%5,769,231
LAMPERT MARK N3.50%5,769,231

Source

View original at SEC

Related